financetom
Business
financetom
/
Business
/
BRIEF-Vista Outdoor Says Enters Into Definitive Agreement With SVP To Sell Revelyst For $1.125 Bln
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Vista Outdoor Says Enters Into Definitive Agreement With SVP To Sell Revelyst For $1.125 Bln
Oct 5, 2024 10:52 AM

Oct 4 (Reuters) - Vista Outdoor Inc ( VSTO ):

* VISTA OUTDOOR ENTERS INTO DEFINITIVE AGREEMENT WITH SVP TO

SELL

REVELYST FOR $1.125 BILLION; DELIVERS AN ESTIMATED $45 PER SHARE

IN CASH IN COMBINATION WITH CSG TRANSACTION

* VISTA OUTDOOR INC ( VSTO ) - CSG INCREASES PURCHASE PRICE FOR

KINETIC

GROUP TO $2.225 BILLION

* VISTA OUTDOOR INC ( VSTO ) - SVP TO PAY $1.125 BILLION, REVELYST

SHAREHOLDERS TO RECEIVE $19.25 PER SHARE

* VISTA OUTDOOR INC ( VSTO ) - CSG TRANSACTION AND SVP TRANSACTION

REPRESENT AN ENTERPRISE VALUE OF $3.35 BILLION FOR VISTA OUTDOOR

* VISTA OUTDOOR INC ( VSTO ) - SVP TRANSACTION HAS BEEN UNANIMOUSLY

APPROVED BY BOARD AND IS EXPECTED TO CLOSE BY JANUARY 2025

* VISTA OUTDOOR INC ( VSTO ) - VISTA OUTDOOR AND CSG HAVE RECEIVED

ALL

REGULATORY APPROVALS REQUIRED UNDER MERGER AGREEMENT FOR CSG

TRANSACTION

* VISTA OUTDOOR INC ( VSTO ) - SVP TRANSACTION CONTINGENT UPON CLOSE

OF CSG

TRANSACTION

Source text for Eikon:

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Applied Industrial Fiscal Q1 Earnings, Sales Rise; Annual EPS Outlook Upgraded
Applied Industrial Fiscal Q1 Earnings, Sales Rise; Annual EPS Outlook Upgraded
Oct 28, 2025
06:58 AM EDT, 10/28/2025 (MT Newswires) -- Applied Industrial Technologies ( AIT ) reported fiscal Q1 earnings Tuesday of $2.63 per diluted share, up from $2.36 a year earlier. Analysts surveyed by FactSet expected $2.49. Net sales for the quarter ended Sept. 30 were $1.2 billion, up from $1.1 billion a year earlier. Analysts polled by FactSet expected $1.19 billion....
Novartis Maintains Outlook Even As Generics Bite Into Profits
Novartis Maintains Outlook Even As Generics Bite Into Profits
Oct 28, 2025
Swiss pharmaceutical major Novartis AG ( NVS ) reported third-quarter 2025 results on Tuesday, reaffirming its full-year guidance as strong sales from key growth drugs offset mounting generic competition in the U.S. The company’s net sales rose 8% year over year to $13.91 billion, missing Wall Street’s consensus estimate of $14.11 billion. On a constant-currency (cc) basis, sales were up...
MSCI's Q3 profit beats on record asset-based fee run rate
MSCI's Q3 profit beats on record asset-based fee run rate
Oct 28, 2025
Overview * MSCI ( MSCI ) Q3 revenue grows 9.5% but misses analyst expectations * Adjusted EPS for Q3 beats consensus, reflecting strong operational performance * Company announces new $3 bln share repurchase program, indicating confidence in future growth Outlook * MSCI ( MSCI ) raises full-year 2025 operating expense guidance to $1,415-$1,445 mln * Financial analytics firm expects full-year...
Prospect Capital Corporation Announces Pricing of $167 Million 5.5% Oversubscribed Institutional Unsecured Notes Offering
Prospect Capital Corporation Announces Pricing of $167 Million 5.5% Oversubscribed Institutional Unsecured Notes Offering
Oct 28, 2025
NEW YORK, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Prospect Capital Corporation ( PSEC ) (“Prospect”, “our”, or “we”) announced today that Prospect priced an institutional offering of approximately $167 million in aggregate principal amount of 5.5% Series A Notes due 2030 (the “Notes”) on October 27, 2025. “We appreciate the strong support and interest we received from over 40 institutional...
Copyright 2023-2026 - www.financetom.com All Rights Reserved